Behan, E., Elsea, D., Abbass, I. M., Moustaid, F. E., Pregenzer, A., Cruz, M. A., Ogale, S., Basho, R. K. (2026). Estimated clinical benefits of timely biomarker testing and matched therapy in HR+/HER2– metastatic breast cancer in the United States: A population model.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e13049